Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 9
Results: 18
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1184, doi. 10.1093/neuonc/noz078
- By:
- Publication type:
- Article
A new study in contrasts: brain MRI for the depiction of tumor metabolism.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1095, doi. 10.1093/neuonc/noz121
- By:
- Publication type:
- Article
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1131, doi. 10.1093/neuonc/noz079
- By:
- Publication type:
- Article
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1164, doi. 10.1093/neuonc/noz098
- By:
- Publication type:
- Article
Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1197, doi. 10.1093/neuonc/noz095
- By:
- Publication type:
- Article
Reply to Dr Stoddard.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1211, doi. 10.1093/neuonc/noz111
- Publication type:
- Article
Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1118, doi. 10.1093/neuonc/noz048
- By:
- Publication type:
- Article
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1141, doi. 10.1093/neuonc/noz090
- By:
- Publication type:
- Article
Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1175, doi. 10.1093/neuonc/noz068
- By:
- Publication type:
- Article
Barriers to accrual and enrollment in brain tumor trials.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1100, doi. 10.1093/neuonc/noz104
- By:
- Publication type:
- Article
Discovery of predictive biomarkers in malignant gliomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1089, doi. 10.1093/neuonc/noz120
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1212, doi. 10.1093/neuonc/noz133
- Publication type:
- Article
HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1091, doi. 10.1093/neuonc/noz115
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1097, doi. 10.1093/neuonc/noz134
- By:
- Publication type:
- Article
Hippocampus avoidance in pediatric patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1093, doi. 10.1093/neuonc/noz110
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1210, doi. 10.1093/neuonc/noz087
- By:
- Publication type:
- Article
Antitumor immune response during glioma virotherapy.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1087, doi. 10.1093/neuonc/noz114
- By:
- Publication type:
- Article
A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1150, doi. 10.1093/neuonc/noz089
- By:
- Publication type:
- Article